用于诊断的生物标志物专利：问题还是解决方案？ - Suppr

Suppr

超能文献

Biomarker patents for diagnostics: problem or solution?

作者信息

Hopkins Michael M, Hogarth Stuart

机构信息

SPRU: Science and Technology Policy Research, University of Sussex, Brighton, UK.

出版信息

Nat Biotechnol. 2012 Jun 7;30(6):498-500. doi: 10.1038/nbt.2257.

DOI:10.1038/nbt.2257

PMID:22678384

Abstract

摘要

相似文献

Biomarker patents for diagnostics: problem or solution?

Nat Biotechnol. 2012 Jun 7;30(6):498-500. doi: 10.1038/nbt.2257.

Diagnostic method patents and harms to follow-on innovation.

Harv Law Rev. 2013 Mar;126(5):1370-91.

Emerging patent issues in genomic diagnostics.

Nat Biotechnol. 2006 Aug;24(8):939-41. doi: 10.1038/nbt0806-939.

Are the gene-patent storm clouds dissipating? A global snapshot.

Nat Biotechnol. 2015 Apr;33(4):347-52. doi: 10.1038/nbt.3182.

The impact of human gene patents on genetic testing in the United Kingdom.

Genet Med. 2011 Apr;13(4):320-4. doi: 10.1097/GIM.0b013e3181fc50bc.

Diagnostics. Amid debate, gene-based cancer test approved.

Science. 2007 Feb 16;315(5814):924. doi: 10.1126/science.315.5814.924.

Myriad Genetics embroiled in breast-cancer data fight - again.

Nature. 2016 May 26;533(7604):449. doi: 10.1038/nature.2016.19953.

The fate and future of patents on human genes and genetic diagnostic methods.

Nat Rev Genet. 2012 May 18;13(6):441-8. doi: 10.1038/nrg3255.

HHS panel examines effects of patents, licenses on genetic testing.

Am J Health Syst Pharm. 2009 Jan 15;66(2):114, 116. doi: 10.2146/news090008.

Supreme Court rules against gene patents.

JAMA. 2013 Jul 24;310(4):357-9. doi: 10.1001/jama.2013.8627.

引用本文的文献

DNA Methylation Cancer Biomarkers: Translation to the Clinic.

Front Genet. 2019 Nov 14;10:1150. doi: 10.3389/fgene.2019.01150. eCollection 2019.

Myriad take two: Can genomic databases remain secret?

Science. 2017 May 12;356(6338):586-587. doi: 10.1126/science.aal3224.

Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.

J Lab Autom. 2016 Aug;21(4):599-608. doi: 10.1177/2211068216651035. Epub 2016 May 23.

The European BRCA patent oppositions and appeals: coloring inside the lines.

Nat Biotechnol. 2013 Aug;31(8):704-10. doi: 10.1038/nbt.2644.

本文引用的文献

A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.

Sociol Health Illn. 2012 Feb;34(2):234-50. doi: 10.1111/j.1467-9566.2011.01411.x. Epub 2011 Nov 25.

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Eur J Hum Genet. 2011 Oct;19(10):1104-7. doi: 10.1038/ejhg.2011.76. Epub 2011 Jun 8.

Medical device recalls and transparency in the UK.

BMJ. 2011 May 13;342:d2973. doi: 10.1136/bmj.d2973.

Overhauling the reimbursement system for molecular diagnostics.

Nat Biotechnol. 2011 May;29(5):390-1. doi: 10.1038/nbt.1869.

DNA patents and diagnostics: not a pretty picture.

Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.

Legal uncertainty in the area of genetic diagnostic testing.

Nat Biotechnol. 2009 Oct;27(10):903-9. doi: 10.1038/nbt1009-903.

The phantom menace of gene patents.

Nature. 2009 Mar 26;458(7237):407-8. doi: 10.1038/458407a.

Scrooge and intellectual property rights.

BMJ. 2006 Dec 23;333(7582):1279-80. doi: 10.1136/bmj.39048.428380.80.

Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.

Health Aff (Millwood). 2006 Sep-Oct;25(5):1281-90. doi: 10.1377/hlthaff.25.5.1281.

New-wave diagnostics.

Nat Biotechnol. 2006 Aug;24(8):931-8. doi: 10.1038/nbt0806-931.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Biomarker patents for diagnostics: problem or solution?

Nat Biotechnol. 2012 Jun 7;30(6):498-500. doi: 10.1038/nbt.2257.

Diagnostic method patents and harms to follow-on innovation.

Harv Law Rev. 2013 Mar;126(5):1370-91.

Emerging patent issues in genomic diagnostics.

Nat Biotechnol. 2006 Aug;24(8):939-41. doi: 10.1038/nbt0806-939.

Are the gene-patent storm clouds dissipating? A global snapshot.

Nat Biotechnol. 2015 Apr;33(4):347-52. doi: 10.1038/nbt.3182.

The impact of human gene patents on genetic testing in the United Kingdom.

Genet Med. 2011 Apr;13(4):320-4. doi: 10.1097/GIM.0b013e3181fc50bc.

Diagnostics. Amid debate, gene-based cancer test approved.

Science. 2007 Feb 16;315(5814):924. doi: 10.1126/science.315.5814.924.

Myriad Genetics embroiled in breast-cancer data fight - again.

Nature. 2016 May 26;533(7604):449. doi: 10.1038/nature.2016.19953.

The fate and future of patents on human genes and genetic diagnostic methods.

Nat Rev Genet. 2012 May 18;13(6):441-8. doi: 10.1038/nrg3255.

HHS panel examines effects of patents, licenses on genetic testing.

Am J Health Syst Pharm. 2009 Jan 15;66(2):114, 116. doi: 10.2146/news090008.

Supreme Court rules against gene patents.

JAMA. 2013 Jul 24;310(4):357-9. doi: 10.1001/jama.2013.8627.

引用本文的文献

DNA Methylation Cancer Biomarkers: Translation to the Clinic.

Front Genet. 2019 Nov 14;10:1150. doi: 10.3389/fgene.2019.01150. eCollection 2019.

Myriad take two: Can genomic databases remain secret?

Science. 2017 May 12;356(6338):586-587. doi: 10.1126/science.aal3224.

Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.

J Lab Autom. 2016 Aug;21(4):599-608. doi: 10.1177/2211068216651035. Epub 2016 May 23.

The European BRCA patent oppositions and appeals: coloring inside the lines.

Nat Biotechnol. 2013 Aug;31(8):704-10. doi: 10.1038/nbt.2644.

本文引用的文献

A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.

Sociol Health Illn. 2012 Feb;34(2):234-50. doi: 10.1111/j.1467-9566.2011.01411.x. Epub 2011 Nov 25.

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Eur J Hum Genet. 2011 Oct;19(10):1104-7. doi: 10.1038/ejhg.2011.76. Epub 2011 Jun 8.

Medical device recalls and transparency in the UK.

BMJ. 2011 May 13;342:d2973. doi: 10.1136/bmj.d2973.

Overhauling the reimbursement system for molecular diagnostics.

Nat Biotechnol. 2011 May;29(5):390-1. doi: 10.1038/nbt.1869.

DNA patents and diagnostics: not a pretty picture.

Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.

Legal uncertainty in the area of genetic diagnostic testing.

Nat Biotechnol. 2009 Oct;27(10):903-9. doi: 10.1038/nbt1009-903.

The phantom menace of gene patents.

Nature. 2009 Mar 26;458(7237):407-8. doi: 10.1038/458407a.

Scrooge and intellectual property rights.

BMJ. 2006 Dec 23;333(7582):1279-80. doi: 10.1136/bmj.39048.428380.80.

Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.

Health Aff (Millwood). 2006 Sep-Oct;25(5):1281-90. doi: 10.1377/hlthaff.25.5.1281.

New-wave diagnostics.

Nat Biotechnol. 2006 Aug;24(8):931-8. doi: 10.1038/nbt0806-931.